UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition CBZEssPharm-250mg-Supp-SE-AJ-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100013348-00011830, http://ema.europa.eu/fhir/eurdId
/539
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Suppository
indication:
Epilepsier. Generaliserade toniska-kloniska anfall (grand mal). Partiella anfall. Karbamazepin är ej verksamt vid absenser (petit mal).
legalStatusOfSupply: Medicinal product subject to medical prescription
classification: carbamazepine
name
productName: Carbamazepine Essential Pharma 250 mg Suppositorium
part
part: Name
type: Scientific Name Part
part
part: 250 mg
type: Strength part
part
part: Suppositorium
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish